Alzheimer’s
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Nov. 2, 2020—Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research.
How proteins spread linked to Alzheimer’s disease sex differences
Jul. 18, 2019—The ways certain proteins spread may help explain why the prevalence of Alzheimer’s is higher in women than in men.
Free memory and Alzheimer’s gene screenings May 14
May. 10, 2019—Staff from the Center for Cognitive Medicine will administer memory screenings and Alzheimer’s gene screenings at no cost to community members ages 60 and above.
Center for Cognitive Medicine offering Alzheimer’s APOE4 Gene Screening
Feb. 12, 2019—Center for Cognitive Medicine offering Alzheimer's APOE4 Gene Screening at Whole Foods on Feb. 18.
Volunteers needed for study exploring Alzheimer’s risk
Jan. 4, 2019—The Center for Cognitive Medicine is seeking volunteers ages 65-75 who have not been diagnosed with any memory impairment and are interested in whether their genetics show they are at increased risk of Alzheimer’s disease.
Center for Cognitive Medicine open house and Alzheimer’s screening
Sep. 4, 2018—Interested in the treatments and prevention of Alzheimer's disease? The Center for Cognitive Medicine is hosting an open house and screening event on Sept. 7.
Enzyme helps build motor that drives neuron death
Aug. 6, 2018—The process, discovered in the axons of neurons, is implicated in Alzheimer’s, amyotrophic lateral sclerosis, traumatic brain injury and other diseases or injuries to the nervous system.
ApoE4 Alzheimer’s Gene Screening on Aug. 3
Aug. 1, 2018—The Center for Cognitive Medicine at Vanderbilt University Medical Center in partnership with the Generation Program will be offering ApoE4 Alzheimer’s Gene Screening on Friday, August 3.
BOLD view of white matter
Jan. 12, 2018—Vanderbilt investigators have discovered that functional MRI detects neural activity in both gray and white matter in the brain, suggesting new ways to investigate diseases such as Alzheimer’s and multiple sclerosis.
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Learn about communication and Alzheimer’s disease at July 20 lunch and learn
Jul. 13, 2016—Do you have a loved one with Alzheimer’s disease or dementia? Are you looking for ways to communicate when words are lost?
Investigators explore African ancestry, Alzheimer’s risk
Apr. 28, 2016—Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia.